Skip to main content
VCbacked
Log inGet Started

BRAINBox Solutions

Richmond, United States

BRAINBox provides objective evidence of injury and prediction of patient recovery.

$7.1M raised
Oct 2023
Series B
BiotechnologyHealth CareWellness

Top Investors

Genoa VenturesAstia AngelsBioventures InvestorsNational Institute of Neurological Disorders and StrokePharmakon Advisors

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about BRAINBox Solutions

How much funding has BRAINBox Solutions raised?
BRAINBox Solutions has raised $7.1M in total funding. The most recent round was Series B. The last funding was announced in October 2023.
Who are BRAINBox Solutions's investors?
BRAINBox Solutions's investors include Genoa Ventures, Astia Angels, Bioventures Investors, National Institute of Neurological Disorders and Stroke, Pharmakon Advisors.
Where is BRAINBox Solutions headquartered?
BRAINBox Solutions is headquartered in Richmond, United States.
What does BRAINBox Solutions do?
BRAINBox provides objective evidence of injury and prediction of patient recovery.
What stage is BRAINBox Solutions at?
BRAINBox Solutions is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"BRAINBox Solutions — Funding & Investors." VCBacked, October 30, 2023, https://www.vcbacked.co/company/brainbox-solutions. Accessed June 17, 2026.
APA
VCBacked. (2023). BRAINBox Solutions — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/brainbox-solutions
Wikipedia (cite web)
{{cite web |title=BRAINBox Solutions — Funding & Investors |url=https://www.vcbacked.co/company/brainbox-solutions |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong